Join us on Saturday, December 2nd for inspiring keynote speakers, dynamic skills workshops, and motivational short stories, all featuring some of medicine's most engaging leaders! We encourage all students interested in healthcare management, hospital administration, venture capitalism, design, coding, and negotiations to attend.
Roderick T. Wong, MD is the managing partner of RTW Investments LLC, a healthcare investment firm in New York. Dr. Wong's background includes previously serving as a portfolio manager and managing director at Davidson Kempner Capital Management LLC, where he was responsible for developing the firm's healthcare investment strategy. Dr. Wong has also worked as a healthcare analyst at Sigma Capital, and as a biotechnology research associate at SG Cowen.
David Asch, MD, MBA, is executive director of the Penn Medicine Center for Innovation. He is professor of medicine, professor of anesthesiology and critical care, and professor of medical ethics and health policy at the Perelman School of Medicine, and he is professor of health care management and professor of operations and information management at the Wharton School.
Dr. Shah is an oncologist at the U.S. Food and Drug Administration. At FDA, his efforts are focused on the intersection of drug development, regulatory science, big data, and health economics. As Intrapreneur-in-Residence, he is scaling the FDA Oncology Center of Excellence big data initiative, Information Exchange and Data Transformation (INFORMED), into a health technology incubator for strategic partnerships, research, and innovation. INFORMED is expanding organizational and technical infrastructure for big data analytics and developing novel approaches to evidence generation in support of regulatory decisions.
Dr. Julian Harris is President of CareAllies, an innovative population health management services company focused on helping physician groups and delivery systems navigate the transition to value-based care. Julian joined Cigna in September 2015 to accelerate the company’s delivery of value-based products and solutions to customers and providers in local markets. He became President of CareAllies in June 2016.
Dr. Flake is an attending surgeon in the Division of Pediatric General, Thoracic and Fetal Surgery and holds the Ruth M. and Tristram C. Colket, Jr. Endowed Chair in Pediatric Surgery at The Children’s Hospital of Philadelphia. He serves as Director of CHOP’s Center for Fetal Research and is a professor of Surgery and Obstetrics and Gynecology at the Perelman School of Medicine at the University of Pennsylvania.
Boston Consulting Group
The Boston Consulting Group (BCG) is a global management consulting firm and the world’s leading advisor on business strategy. Now in our sixth decade, we continue not only to grow but also to embody the same timeless sense of purpose and the constant call for renewal that our founder Bruce Henderson instilled at our inception.
Jounce Therapeutics, Inc., a clinical stage immunotherapy company, focuses on developing therapies that enable the immune system to attack tumors. Its lead product candidate, JTX-2011, is a clinical stage monoclonal antibody that binds to and activates ICOS, a protein on the surface of certain T cells commonly found in various solid tumors. The company is also developing JTX-4014, an anti-PD-1 antibody.
Date and Time
Sat, December 2, 2017
10:00 AM – 4:00 PM EDT
Jordan Medical Education Center
3400 Civic Center Blvd